Viatris Suppliers Want Out Of J&J Unit's MS Drug IP Suit
Three drug manufacturers for Viatris have urged a Pennsylvania federal judge to cut them loose from a patent suit lodged by a Johnson & Johnson branch over a generic multiple sclerosis...To view the full article, register now.
Already a subscriber? Click here to view full article